The introduction of the 505(b)(2) application pathway by the USFDA has turned out to be a game-changer for pharma companies. Not only has it led to faster drug approvals compared…
October 8, 2024
The introduction of the 505(b)(2) application pathway by the USFDA has turned out to be a game-changer for pharma companies. Not only has it led to faster drug approvals compared…